Showing 161-170 of 3329 results for "".
Octane Aesthetics Tech Forum: Artificial Intelligence’s Expanding Role in Aesthetic Medicine
https://modernaesthetics.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-artificial-intelligences-expanding-role-in-aesthetic-medicine/54705/Jessica Wu, MD, Dermatologist, Author, and Founder & CEO of Residen, offers a grounded perspective on AI in aesthetics moving beyond hype to real-world application. She shares how AI is influencing clinical decision-making, where it is delivering measurable value in practice, and which emergingFace Value with Modern Aesthetics: Dr. Lisa Espinoza Debunks Misinformation Surrounding HA fillers
https://modernaesthetics.com/series/face-value/face-value-with-modern-aesthetics-dr-lisa-espinoza-debunks-misinformation-surrounding-ha-fillers/49192/Lisa Espinoza, MD, discusses the Naturally You with Injectable Hyaluronic Acid Fillers report—and how she will incorporate this data with patients interested in HA fillers.Face Value with Modern Aesthetics: AAFPRS’s Humanitarian Effort in Ukraine
https://modernaesthetics.com/series/face-value/face-value-with-modern-aesthetics-aafprss-humanitarian-effort-in-ukraine/39703/Face Value with Modern Aesthetics is a new video series in which we connect with leading experts in aesthetic medicine to discuss the latest innovations, insights, and trends shaping the industry. In this week’s episode, Manoj Abraham, MD, FACS, discusses the American Academy of Facial Plastic and ROctane Aesthetics Tech Forum: Longevity Medicine Specialist Dr. Elizabeth Yurth Excited Field Is Entering Aesthetics
https://modernaesthetics.com/conferences/octane-atf/octane-aesthetics-tech-forum-longevity-medicine-specialist-dr-elizabeth-yurth-excited-field-is-entering-aesthetics/33858/Elizabeth Yurth, MD, ABARM, FAARM, FSSP, is co-founder and chief medical officer of Boulder Longevity Institute in Colorado. Dr. Yurth has a profound background specializing in orthopedic medicine prior to adventuring into the longevity, regenerative, and anti-aging medicine specialty. Dr. Yurth telOctane Aesthetic Tech Forum: Dr. Jason Bloom Dives into Why He’s Held Out on Partnering with Private Equity Firm
https://modernaesthetics.com/conferences/octane-atf/voctane-aesthetic-tech-forum-dr-jason-bloom-dives-into-why-hes-held-out-on-partnering-with-private-equity-firm/33857/Jason Bloom, MD, FACS, is on Octane’s medical aesthetics advisory board. At this year’s forum, Dr. Bloom was part of the Private Equity in Aesthetics Debate. He shared where he stands with Modern Aesthetics.Octane Aesthetics Tech Forum: Octane CEO Bill Carpou Talks Planning Process, Excitement Surrounding Industry
https://modernaesthetics.com/conferences/octane-atf/octane-aesthetics-tech-forum-octane-ceo-bill-carpou-talks-planning-process-excitement-surrounding-industry-1/33854/Modern Aesthetics sat down with Octane CEO Bill Carpou to discuss the Aesthetics Tech Forum planning process and highlight some panels he was excited to sit in on.Introducing Modern Aesthetic's New Chief Medical Editor as We Relaunch MATV News
https://modernaesthetics.com/series/matv-news/matv-725/33805/In this week's MATV News, we introduce Modern Aesthetic's new chief medical editor Dr. Saami Khalifian; discuss rising concerns over the tween skincare craze; and a major British cosmetic surgery chain ceases operations.MATV News: Endo Pulls Qwo from Market; Merz Aesthetics Adds SaltFacial; Current Trends in Aesthetic Medicine
https://modernaesthetics.com/series/matv-news/matv-news-endo-pulls-qwo-from-market-merz-aesthetics-adds-saltfacial-current-trends-in-aesthetic-medicine/33713/Endo International is ceasing the production and sale of Endo Aesthetics' injectable cellulite treatment Qwo; Merz Aesthetics is adding the SaltFacial to its portfolio through an extended commercial agreement with SaltMED; and New York City dermatologist Dr. Robert Finney discusses trends in aesthetMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News Extra: The Lowdown on Allergan Alle Flash
https://modernaesthetics.com/series/matv-news/matv-news-extra-the-lowdown-on-allergan-alle-flash/33682/Jasson Gilmore, Co-Founder of Allergan Data Labs, discusses the evolution of Allergan's Alle loyalty program and the launch of the Alle Flash. He shares insights on the benefits for patients and providers.